Amid PAMA Implementation, Stakeholders Contemplate Coding to Facilitate Market-Based MDx Pricing | GenomeWeb

NEW YORK (GenomeWeb) – The American Medical Association is currently working with stakeholders to figure out how coding requirements under a new Medicare law can be implemented within the CPT coding framework it has developed and owns the copyrights to.

However, these efforts raise questions about the viability of unique identifiers developed by McKesson, called Z-Codes, which according to the information technology firm are already being used by a portion of the lab industry, one Medicare contractor, and several private payors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.